Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Head and Neck Neoplasms 1Deglutition Disorders 1Communication Disorders 1Breast Neoplasms 1Advanced Breast Cancer 1

Interventions

Fulvestrant 9olaparib 4Capecitabine 4pyrotinib 3Injections 3Docetaxel 3trastuzumab deruxtecan 2toripalimab 2Vinorelbine 2Trastuzumab 2Letrozole 2Goserelin 2Alpelisib 2vandetanib 1talazoparib 1sacituzumab govitecan 1pembrolizumab 1neratinib 1liposomal doxorubicin 1exemestane 1eribulin 1dalpiciclib 1ceralasertib 1cediranib 1capivasertib 1abemaciclib 1Tablets 1Paclitaxel 1Moxifloxacin 1Lead 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Breast Cancer × Lead × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡